✦ LIBER ✦

P218 The association of MDM2 T309G with oral cancer and precancer in Malaysians

✍ Scribed by Ismail, S.M.; Hamid, S.; Yang, Y.H.; Ghani, W.M.N.; Lim, K.P.; Ng, L.P.K.; Zain, R.B.; Latifah, R.J.R.; Razak, I.A.; Abdullah, N.; Teo, S.H.; Cheong, S.C.

Book ID: 118655946
Publisher: Elsevier Science
Year: 2007
Weight: 51 KB
Volume: 2
Category: Article
ISSN: 1744-7895
DOI: 10.1016/s1744-7895(07)70495-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No evidence for association of the MDM2-

No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes

✍ Jerry J. Jaboin; Misun Hwang; Carmen A. Perez; Calvin Cooper; Heidi Chen; Chuanz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 307 KB

The TP53 Arg72Pro and MDM2 309G>T polymo

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

✍ Sinilnikova, O M; Antoniou, A C; Simard, J; Healey, S; Léoné, M; Sinnett, D; Spu 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

The functional MDM2 T309G genetic varian

The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis

✍ Xu Cai; Ming Yang 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 236 KB

105 Association of the germline MDM2 SNP

105 Association of the germline MDM2 SNP309 and TP53 R72P variants with breast cancer survival in specific tumour subgroups

✍ A.J. van den Broek; A. Broeks; H. Horlings; L.M. Braaf; L.J. Van't Veer; M.K. Sc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

The association between the T309G polymo

The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models

✍ Faur, N; Araud, L; Laroche-Clary, A; Kanno, J; Toutain, J; Yamori, T; Robert, J; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 236 KB

MDM2 SNP309 T>G alone or in combination

MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients

✍ Bente A. Talseth; Cliff Meldrum; Janina Suchy; Grzegroz Kurzawski; Jan Lubinski; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 64 KB 👁 1 views

## Abstract Disease expression in hereditary nonpolyposis colorectal cancer (HNPCC) cannot be readily explained by mutation site in the respective DNA mismatch repair genes associated with this disorder. One explanation is the role of modifying genes that can either promote or prevent disease devel